Cargando…

Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients

Cardiovascular abnormalities, such as left ventricular hypertrophy and valvular disorders, particularly mitral valve prolapse, have been described as highly prevalent among adult patients with autosomal dominant polycystic kidney disease (ADPKD). The present study aimed to assess echocardiographic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeferman, Mariana Becker, da Rocha, Daniel Ribeiro, Rodrigues, Fernanda Guedes, Pfeferman, Elcio, Heilberg, Ita Pfeferman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604303/ https://www.ncbi.nlm.nih.gov/pubmed/36294302 http://dx.doi.org/10.3390/jcm11205982

Ejemplares similares

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Vendramini, Larissa Collis, et al.
Publicado: (2019)

Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD
por: dos Santos Dutra, Adriana, et al.
Publicado: (2022)

Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease
por: Facioli, Roberta, et al.
Publicado: (2021)

The necessary pathway for metabolic and crystallographic analysis of kidney stones: struvite may not differ from its counterparts
por: Pietrobom, Igor, et al.
Publicado: (2021)

Dietary pattern analysis among stone formers: resemblance to a DASH-style diet
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2020)

Influence of socioeconomic disparities, temperature and humidity in kidney stone composition
por: Cunha, Tamara da Silva, et al.
Publicado: (2020)

Bartter syndrome: causes, diagnosis, and treatment
por: Cunha, Tamara da Silva, et al.
Publicado: (2018)

Adult presentation of Bartter syndrome type IV with erythrocytosis
por: Heilberg, Ita Pfeferman, et al.
Publicado: (2015)

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts
por: Moyes, S, et al.
Publicado: (2012)

Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.
por: Tessaro, Carolini Zanette Warmling, et al.
Publicado: (2018)

Thiazide and thiazide-like diuretics in nephrolithiasis
por: Cunha, Tamara da Silva, et al.
Publicado: (2020)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Bone turnover after bariatric surgery
por: Melo, Thalita Lima, et al.
Publicado: (2017)

Urinary Calcium Is Associated with Serum Sclerostin among Stone Formers
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2023)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2020)

COVID-19: The impact on urolithiasis treatment in Brazil
por: Korkes, Fernando, et al.
Publicado: (2021)

Overweight and body fat are predictors of hypovitaminosis D in renal transplant patients
por: Baxmann, Alessandra Calábria, et al.
Publicado: (2015)

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
por: McEwan, Phil, et al.
Publicado: (2018)

Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
por: McBride, Lucy, et al.
Publicado: (2020)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation
por: Zubidat, Dalia, et al.
Publicado: (2023)

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease
por: Hasegawa, Eiko, et al.
Publicado: (2016)

Caffeine intake by patients with autosomal dominant polycystic kidney disease
por: Vendramini, L.C., et al.
Publicado: (2012)

N-acetylcysteine protects against star fruit-induced acute kidney injury
por: Shimizu, Maria Heloisa Massola, et al.
Publicado: (2016)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss
por: Peces, Ramón, et al.
Publicado: (2008)

Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Maxeiner, Andreas, et al.
Publicado: (2019)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
por: Harris, Tess, et al.
Publicado: (2018)

Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?
por: Ietto, Giuseppe, et al.
Publicado: (2019)

Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2022)

Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients
por: Chiha, Joseph, et al.
Publicado: (2012)

Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
por: Dudley, Jan, et al.
Publicado: (2019)

Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
por: Agraz-Pamplona, I., et al.
Publicado: (2020)

Total and Extracellular Vesicle cAMP Contents in Urine Are Associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression
por: Rosenberg, María Lucía, et al.
Publicado: (2023)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Carrera, Paola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bt975igm9g70f26s2kbsqvojjf